These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6772381)

  • 1. Antiarrhythmic efficacy, pharmacokinetics and clinical safety of tocainide in convalescent myocardial infarction patients.
    Klein MD; Levine PA; Ryan TJ
    Chest; 1980 Jun; 77(6):726-30. PubMed ID: 6772381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocainide for refractory ventricular arrhythmias of myocardial infarction.
    Haffajee CI; Alpert JS; Dalen JE
    Am Heart J; 1980 Dec; 100(6 Pt 2):1013-6. PubMed ID: 6778188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and antiarrhythmic effects of tocainide in patients with acute myocardial infarction.
    Nyquist O; Forssell G; Nordlander R; Schenck-Gustafsson K
    Am Heart J; 1980 Dec; 100(6 Pt 2):1000-5. PubMed ID: 6778186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis of ventricular tachyarrhythmias with intravenous and oral tocainide in patients with and recovering from acute myocardial infarction.
    Rydén L; Arnman K; Conradson TB; Hofvendahl S; Mortensen O; Smedgård P
    Am Heart J; 1980 Dec; 100(6 Pt 2):1006-12. PubMed ID: 6778187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of tocainide and lidocaine in patients admitted for suspected acute myocardial infarction.
    Rehnqvist N; Erhardt L; Ericsson CG; Olsson G; Svensson G; Sjögren A
    Acta Med Scand; 1983; 214(1):21-7. PubMed ID: 6414252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral tocainide versus disopyramide: a double-blind, randomized, crossover study of outpatients with stable ventricular premature beats.
    McLaran CJ; Hossack KF; Neilson GH; Siskind V
    J Cardiovasc Pharmacol; 1984; 6(4):657-62. PubMed ID: 6206321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias.
    Morganroth J; Oshrain C; Steele PP
    Am J Cardiol; 1985 Oct; 56(10):581-5. PubMed ID: 3931448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized trial of tocainide in patients following myocardial infarction.
    Bastian BC; Macfarlane PW; McLauchlan JH; Ballantyne D; Clark P; Hillis WS; Rae AP; Hutton I
    Am Heart J; 1980 Dec; 100(6 Pt 2):1017-22. PubMed ID: 6778189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the uses and limitations of tocainide--a class IB antiarrhythmic agent.
    Morganroth J; Nestico PF; Horowitz LN
    Am Heart J; 1985 Oct; 110(4):856-63. PubMed ID: 3931446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and haemodynamic effects of tocainide in patients with acute myocardial infarction complicated by left ventricular failure.
    MacMahon B; Bakshi M; Branagan P; Kelly JG; Walsh MJ
    Br J Clin Pharmacol; 1985 Apr; 19(4):429-34. PubMed ID: 3922392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide.
    Winkle RA; Meffin PJ; Fitzgerald JW; Harrison DC
    Circulation; 1976 Dec; 54(6):885-9. PubMed ID: 791536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tocainide and prajmalium bitartrate for the treatment of ventricular arrhythmias.
    Schwartzkopff B; Schilling G; Simon H
    Arzneimittelforschung; 1983; 33(1):153-8. PubMed ID: 6403021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative studies of tocainide and propafenone in the treatment of ventricular arrhythmias].
    Gebhardt A; Schmuderer R; Hilpert P
    Arzneimittelforschung; 1984; 34(3):303-6. PubMed ID: 6428425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
    Goedel-Meinen L; Hofmann M; Schmidt G; Barthel P; Baedeker W; Blömer H
    Herz; 1988 Jun; 13(3):188-96. PubMed ID: 3136064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
    Hellestrand KJ
    Eur Heart J; 1984 Sep; 5 Suppl B():87-94. PubMed ID: 6437822
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylaxis of primary ventricular fibrillation with tocainide in acute myocardial infarction.
    Campbell RW; Hutton I; Elton RA; Goodfellow RM; Taylor E
    Br Heart J; 1983 Jun; 49(6):557-63. PubMed ID: 6405764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocainide. A review of its pharmacological properties and therapeutic efficacy.
    Holmes B; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Aug; 26(2):93-123. PubMed ID: 6411445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.
    Allen-Narker RA; Roberts CJ; Marshall AJ; Jordan SC; Barritt DW; Goodfellow RM
    Br J Clin Pharmacol; 1984 Nov; 18(5):725-32. PubMed ID: 6439233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocainide: a new oral antiarrhythmic.
    Hasegawa GR
    Drug Intell Clin Pharm; 1985; 19(7-8):514-7. PubMed ID: 3928308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic tocainide or lidocaine in acute myocardial infarction.
    Keefe DL; Williams S; Torres V; Flowers D; Somberg JC
    Am J Cardiol; 1986 Mar; 57(8):527-31. PubMed ID: 3082175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.